Newsweek on MSN13d
UnitedHealth Charged Cancer Patients 5000%, Bombshell FTC Report ClaimsThe FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
At a public meeting held on January 15, 2025, the Federal Trade Commission (FTC) summarized the Second Interim Staff Report ...
In the report, the FTC said pharmacy benefit managers (PBMs), charge significant markups for cancer, HIV, and other critical ...
A staff report released Friday by the FTC suggested partnerships between OpenAI and Microsoft, and Amazon and Anthropic, ...
The U.S. Federal Trade Commission (FTC) on Friday found that the partnerships between Microsoft ( NASDAQ: MSFT ), Amazon ( ...
On January 17, 2025, the staff at the Federal Trade Commission (FTC) released their first results from the FTC’s Surveillance Pricing market ...
TechCrunch on MSN7d
FTC says partnerships like Microsoft-OpenAI raise antitrust concernsThe Federal Trade Commission (FTC) said in a staff report issued Friday that there are potential competitive issues in ...
America's largest health care company, UnitedHealth, made profits of more than 5,000 percent on a lifesaving leukemia drug, according to a Federal Trade Commission report. The December murder of ...
GREEN BAY, Wis. (WBAY) - It’s Identity Theft Awareness Week. Identity theft can happen to anyone, but there are resources to ...
The Federal Trade Commission has released its second report digging into how the business practices of pharmacy benefit managers could be inflating drug costs in the U.S., in the latest and likely ...
The Federal Trade Commission (“FTC”) released its second interim report on Jan. 14, 2025, accusing pharmacy benefit managers (PBMs) of marking up the prices of specialty generic drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback